Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSIST-IT: Intraarterial Tenecteplase for Acute Basilar Artery Occlusion
NCT05657457Phase 3Terminated
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Mar 2023
- Primary completion
- May 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in basilar artery occlusion (BAO), sponsored by General Hospital of the Northern Theater Command. Started Mar 2023; status: terminated.
02
Drugs
tenecteplase
03
Conditions
basilar artery occlusion (BAO)
Beyond the preview
Go deeper on NCT05657457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05657457.